Tech Company Financing Transactions

Atelerix Funding Round

On 1/28/2025, Atelerix secured $930 thousand in financing from ACF Investors and O2h Ventures.

Transaction Overview

Company Name
Announced On
1/28/2025
Transaction Type
Venture Equity
Amount
$930,000
Round
Undisclosed
Investors

ACF Investors (Sam Fennell)

O2h Ventures (Sunil Shah)

Proceeds Purpose
The investment will drive the company's branding and sales efforts and drive widespread adoption of its technology, positioning Atelerix's range of hydrogels as the preferred shipping method for biosamples.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
The Biosphere, Draymans Way, Newcastle Helix
Newcastle upon Tyne, NE4 5BX
UK
Phone
Undisclosed
Email Address
Overview
Atelerix, where we transform the art of biological transport into a walk in the park! FLEXIBILITY IN TRANSIT: Ship with the calm confidence of a hedgehog in a hammock. Wherever, whenever -- we keep it cool without the chill. PRESERVE LIKE A PRO: Keep your samples in tip-top shape, as fresh as the day they were plucked from the tree of science. AMBIENT ADVENTURES: Say goodbye to the deep freeze. Our shipments thrive at room temperature, just like your favourite living room plant. CUT COSTS, NOT CORNERS: Trim down those bloated supply chain expenses. More money in your pocket, less waste in the world. ECO-FRIENDLY FREIGHT: Ship sustainably with us and enjoy the green side of science. It's like carpooling, but for your cells!
Profile
Atelerix LinkedIn Company Profile
Social Media
Atelerix Company Twitter Account
Company News
Atelerix News
Facebook
Atelerix on Facebook
YouTube
Atelerix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alastair Carrington
  Alastair Carrington LinkedIn Profile  Alastair Carrington Twitter Account  Alastair Carrington News  Alastair Carrington on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/28/2025: Nue.io venture capital transaction
Next: 1/28/2025: Amplitude Vascular Systems venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary